👩
主题枢纽
女性专用肽
荷尔蒙平衡、皮肤健康、体重管理和更年期支持--专门针对女性健康问题研究的肽。
关键肽
研究
Model-Informed Drug Development (MIDD) / Post-hoc AnalysisPubMed
Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model-Informed Drug Development Approach
This Novo Nordisk study used model-informed drug development to evaluate whether semaglutide 1.7 mg …
Semaglutide
Systematic Review and Meta-AnalysisPubMed
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Depression: A Systematic Review and Meta-Analysis
This comprehensive meta-analysis evaluated the association between GLP-1 receptor agonist use and de…
GLP-1 receptor agonistssemaglutideliraglutide
Retrospective cohort study (n=293)PubMed
Real-World Weight-Loss Outcomes in Weight-Reduced Patients Treated With Tirzepatide
This real-world study of 293 patients found that tirzepatide produced 10.3% total body weight loss i…
TirzepatideSemaglutide
Systematic review and meta-analysisPubMed
Glucagon-like Peptide-1 Receptor Agonists and Risk of Depression: A Systematic Review and Meta-Analysis
This comprehensive meta-analysis examined the relationship between GLP-1 receptor agonist use and de…
GLP-1 receptor agonistsSemaglutideLiraglutide
Biobank cohort analysis (n=93,936)PubMed
Semaglutide Efficacy Varies Across Ancestries and Is Modulated by Genetic Variation in PTPRU
Analysis of 93,936 participants from the UCLA ATLAS Community Health Initiative revealed that semagl…
Semaglutide
Early Phase 1 interventional trial (n=36, recruiting)ClinicalTrials.gov
Tirzepatide/Semaglutide Weight Loss Intervention in Patients With Endometrial Cancer and Obesity
Memorial Sloan Kettering is conducting a pilot study evaluating tirzepatide (with semaglutide as alt…
TirzepatideSemaglutide